Methimazole-Induced Cholestatic Jaundice: A Rare Case and Literature Review
Methimazole is commonly prescribed for patients with hyperthyroidism. It typically exhibits a well-tolerated profile, with common side effects including gastrointestinal disorders and rash. However, more serious rare yet adverse reactions, notably agranulocytosis and hepatotoxicity have been documen...
Saved in:
Main Authors: | Ahmed Mohamed Nefzi, Dhouha Cherif, Habiba Dabbebi, Haythem Yacoub, Hajer Hassine, Hela Kchir, Khadija Bellil, Nadia Maamouri |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/23247096251317285 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cephalexin Induced Cholestatic Jaundice
by: Abhinav Agrawal, et al.
Published: (2014-01-01) -
Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer
by: Tomomi Kuramoto, et al.
Published: (2013-01-01) -
Unusual Case of an Infant with Urinary Tract Infection Presenting as Cholestatic Jaundice
by: Rahaf Niazi, et al.
Published: (2018-01-01) -
Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave’s Disease—A Case Report and Review of the Literature
by: Tawfik Khoury, et al.
Published: (2015-01-01) -
Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case
by: Rıfkı Üçler, et al.
Published: (2015-01-01)